ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.020
-0.020 (-1.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.049
+0.029 (2.79%)
After-hours: Jun 26, 2026, 7:00 PM EDT

ADC Therapeutics Stock Forecast

ADCT's stock price has decreased by -63.04% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 5.67, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 455.88% from the current stock price of 1.02.

Analyst Consensus: Buy
Target Low Average Median High
Price $2.00 $5.67 $5.00 $10
Change +96.08% +455.88% +390.20% +880.39%

Analyst Ratings

The average analyst rating for ADC Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 555553
Buy 111110
Hold 000002
Sell 000000
Strong Sell 000000
Total 666665

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
H.C. Wainwright
H.C. Wainwright
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 8, 2026
Guggenheim
Guggenheim
Buy
Maintains
$10
Buy Maintains $10 +880.39% Jun 5, 2026
Stephens
Stephens
Buy
Reiterates
$5
Buy Reiterates $5 +390.20% Jun 4, 2026
RBC Capital
RBC Capital
Hold
Downgrades
$6$2
Hold Downgrades $6$2 +96.08% Jun 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
81.46M
from 81.36M
Increased by 0.13%
Revenue Next Year
124.04M
from 81.46M
Increased by 52.27%
EPS This Year
1.02
EPS Next Year
2.27
from 1.02
Increased by 122.55%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
33.92M209.91M69.56M70.84M81.36M81.46M124.04M
Revenue Growth
-518.89%-66.86%1.84%14.85%0.13%52.27%
EPS
-3.00-2.01-2.94-1.62-1.12-0.85-0.66
EPS Growth
-------
Forward PE
-------
No. Analysts -----54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 88.1M 140.6M
Avg 81.5M 124.0M
Low 73.4M 117.0M

Revenue Growth

Revenue Growth 202620272028
High
8.3%
72.6%
Avg
0.1%
52.3%
Low
-9.8%
43.7%

EPS Forecast

EPS 202620272028
High 1.02 2.27
Avg 1.02 2.27
Low 1.02 2.27

EPS Growth

EPS Growth 20272028
High
122.5%
-
Avg
122.5%
-
Low
122.5%
-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.